STOCK TITAN

Accuray to Report Second Quarter Fiscal 2024 Financial Results on January 31, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2024, ended December 31, 2023, during a conference call on January 31, 2024. The conference call will be hosted by company management and a live webcast will be available. Investors can access the webcast replay from the Investor Relations section of the company's website. The dial-in numbers for the conference call and the replay numbers are provided for both USA and international participants.
Positive
  • None.
Negative
  • None.

MADISON, Wis., Jan. 16, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2024, ended December 31, 2023, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on January 31, 2024.

The conference call dial-in numbers are (833) 316-0563 (USA) or (412) 317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call's conclusion for one week. The replay number is (877) 344-7529 (USA) or (412) 317-0088 (international), conference ID: 1227335.

A live webcast of the call will also be available from the Investor Relations section of the company's website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the third quarter of fiscal 2024.

About Accuray
Accuray Incorporated (Nasdaq: ARAY) is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor Contact
Aman Patel, CFA
Investor Relations, ICR-Westwicke
+1 (443) 450-4191
aman.patel@westwicke.com 

Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
bkaplan@accuray.com 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-second-quarter-fiscal-2024-financial-results-on-january-31-2024-302036341.html

SOURCE Accuray Incorporated

FAQ

When will Accuray Incorporated report financial results for the second quarter of fiscal year 2024?

Accuray Incorporated will report financial results for the second quarter of fiscal year 2024 on January 31, 2024.

What is the ticker symbol for Accuray Incorporated?

The ticker symbol for Accuray Incorporated is ARAY.

How can I access the live webcast of the conference call?

The live webcast of the conference call will be available from the Investor Relations section of the company's website at investors.accuray.com.

How long will the webcast replay be available?

The webcast replay can be accessed on the website and will remain available until Accuray announces its results for the third quarter of fiscal 2024.

What are the dial-in numbers for the conference call?

The dial-in numbers for the conference call are (833) 316-0563 (USA) or (412) 317-5747 (international).

What are the replay numbers for the conference call?

The replay number is (877) 344-7529 (USA) or (412) 317-0088 (international), conference ID: 1227335.

Accuray Incorporated

NASDAQ:ARAY

ARAY Rankings

ARAY Latest News

ARAY Stock Data

160.65M
88.53M
3.58%
66.36%
5.31%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
MADISON

About ARAY

accuray incorporated (nasdaq: aray) is a radiation oncology company that develops, manufactures and sells precise, innovative tumor treatment solutions that set the standard of care with the aim of helping patients live longer, better lives. the company's leading-edge technologies deliver the full range of radiation therapy and radiosurgery treatments. for more information, please visit www.accuray.com. for career opportunities, please visit http://www.accuray.com/careers.